Relic Technologies
add_icon

Relic Technologies

67.71
-1.96
(-2.81%)
Market Cap
37.90 Cr
PE Ratio
-8.60
Volume
170.00
Day High - Low
74.85 - 63.16
52W High-Low
93.96 - 58.20
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
37.90 Cr
EPS
-4.13
PE Ratio
-8.60
PB Ratio
2.08
Book Value
33.42
EBITDA
-1.10
Dividend Yield
0.00 %
Return on Equity
-17.02
Debt to Equity
0.19
Forecast For
Actual

Company News

View All News
Caret
neutral
Promoter Alisha Kunal Gandhi acquired 5,000 additional shares in Relic Technologies through open market purchase, increasing promoter group holding to 44.93% from 44.84%.
positive
Alisha Kunal Gandhi acquired 2,000 additional equity shares through open market purchase on March 16, 2026, raising promoter group holding from 44.80% to 44.84% in Relic Technologies Limited.
neutral
Relic Technologies Limited announced its unaudited financial results for the quarter ended September 30, 2025. On a standalone basis, the company reported a net profit of Rs 17.52 lakhs for the quarter compared to Rs 9.75 lakhs in the previous quarter. However, on a consolidated basis, the company posted a net loss of Rs 2.30 lakhs for the quarter. For the half-year period, standalone net profit was Rs 19.19 lakhs while consolidated operations showed a net loss of Rs 353.39 lakhs. The company's total income on a standalone basis was Rs 34.81 lakhs for the quarter. The Board also approved the voluntary striking off of its non-operative subsidiary Relic Pharma Limited, which had nil turnover and negligible net worth of Rs 1.019 lakhs. The strike-off process is expected to be completed by March 31, 2026, subject to regulatory approval. The company's paid-up equity share capital increased to Rs 515 lakhs from Rs 360 lakhs. The results were reviewed by auditors D. Kothary & Co., who provided an unmodified opinion.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
26.50
#1 1,847.34
1,262.00
106.40
-
6
-70.24
40.57
52.52
1,476.32
83.69
234.70
49.78
32
15.69
41.31
162.00
1,244.35
666.46
14.40
-84.02
2
-56.30
35.31
101.05
1,231.73
68.26
0.50
-70.59
-0
#1 1,350.00
69.05
276.45
937.17
34.54
89.40
34.23
39
-74.39
51.14
823.35
877.28
37.14
60.10
-10.30
34
-91.40
39.17
260.45
652.70
21.53
923.40
-2.09
20
58.33
49.88
751.95
524.26
36.15
14.60
#1 305.56
1
315.38
100.00
96.20
502.57
#1 13.84
365.00
19.40
#1 46
124.56
48.39
123.21
414.87
-
#1 1,152.20
14.25
2
-69.34
64.78
Growth Rate
Revenue Growth
25.00 %
Net Income Growth
66.67 %
Cash Flow Change
-260.87 %
ROE
-3.30 %
ROCE
-14.57 %
EBITDA Margin (Avg.)
29.79 %

Quarterly Financial Results

Quarterly Financials
Mar 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
1
1
0
1
0
0
0
1
0
0
0
0
0
1
1
0
2
1
1
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
1
1
1
1
1
5
2
2
EBITDA
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
-1
0
0
0
-1
-0
-4
-1
-2
Operating Profit %
19 %
48 %
50 %
27 %
6 %
70 %
25 %
30 %
27 %
17 %
32 %
28 %
38 %
52 %
15 %
38 %
50 %
24 %
14 %
49 %
17 %
16 %
-4 %
-21 %
-10 %
-7 %
-171 %
-17 %
-17 %
27 %
-204 %
-64 %
-294 %
-145 %
-513 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
-0
-0
-1
-0
-0
0
-1
-1
-4
-1
-2
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-1
Net Profit
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
-0
-0
-0
-0
-1
-0
-0
0
-1
-1
-4
0
-1
EPS in ₹
0.04
0.41
0.07
0.08
0.16
2.87
-0.02
0.16
0.14
0.07
0.05
0.08
0.39
0.55
0.06
0.42
0.62
0.35
-0.01
0.65
0.18
0.14
-0.44
-0.30
-0.15
-0.15
-1.81
-0.29
-0.29
0.40
-2.77
-1.46
-7.25
0.30
-0.92

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
5
5
5
5
5
5
6
6
6
6
13
Fixed Assets
1
1
1
1
1
0
0
1
1
1
4
Current Assets
3
3
3
3
4
4
5
5
5
5
9
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
4
4
4
4
5
5
5
5
6
5
9
Total Equity & Liabilities
5
5
5
5
5
5
6
6
6
6
13
Current Liabilities
0
0
0
0
0
0
0
0
0
1
3
Non Current Liabilities
1
1
1
1
0
0
0
0
0
0
1
Total Equity
4
4
4
4
5
5
5
6
6
5
9
Reserve & Surplus
0
0
0
0
1
1
2
2
2
2
0
Share Capital
4
4
4
4
4
4
4
4
4
4
4

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
0
0
0
2
-1
0
0
0
0
6
Investing Activities
-0
0
0
-0
0
0
0
0
-0
-1
2
Operating Activities
0
0
0
0
2
-0
0
0
0
0
-0
Financing Activities
0
-0
-0
-0
-0
-0
-0
0
0
0
4

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
May 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.22 %
66.60 %
46.55 %
46.55 %
46.55 %
44.78 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.02 %
0.02 %
0.02 %
0.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
28.54 %
29.10 %
29.13 %
29.05 %
29.31 %
29.24 %
29.11 %
29.03 %
29.03 %
29.03 %
29.06 %
29.12 %
28.89 %
29.21 %
29.35 %
29.37 %
28.85 %
41.21 %
39.43 %
37.44 %
34.38 %
Others
5.22 %
4.65 %
4.62 %
4.70 %
4.44 %
4.52 %
4.64 %
4.73 %
4.73 %
4.73 %
4.70 %
4.64 %
4.87 %
4.54 %
4.40 %
4.39 %
4.53 %
12.21 %
14.00 %
15.98 %
20.82 %
No of Share Holders
1,257
1,322
1,382
1,492
1,528
1,524
1,487
1,508
1,538
1,574
1,692
1,766
1,913
1,988
2,123
2,188
2,092
2,084
2,079
2,073
2,014

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20112 days ago
Closure of Trading Window6 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 18, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 16, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Statement Of Utilization/ Deviation Of Funds Of Preferential Issue For The Quarter And Nine Months Ended December 31 2025Feb 12, 2026
Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 12, 2026
Board Meeting Outcome for Held On February 12 2026Feb 12, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2025Feb 03, 2026
Announcement Under Regulation 30 (LODR): Deferral Of Proposed Extra Ordinary General MeetingJan 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Closure of Trading WindowDec 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 16, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 16, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 16, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 16, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 16, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressDec 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 13, 2025
Announcement under Regulation 30 (LODR)-AllotmentDec 13, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On December 13 2025.Dec 13, 2025
Board Meeting Intimation for Considering Inter Alia Approval Of Employee Stock Option SchemeDec 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Statement Of Utilization/ Deviation Of Funds Of Preferential Issue For The Quarter Ended September 30 2025Nov 08, 2025
Voluntary Striking Off Of Non-Operative Subsidiary Company Namely Relic Pharma Limited.Nov 08, 2025
Financial Results For The Quarter And Half Year Ended On September 30 2025Nov 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On November 08 2025Nov 08, 2025
Board Meeting Intimation for For Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Closure of Trading WindowSep 27, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationAug 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 29, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Reg. 34 (1) Annual Report.Aug 06, 2025
34Th Annual General Meeting To Be Held On Friday 29Th August 2025.Aug 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 01, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th July 2025Jul 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Appointment of Company Secretary and Compliance OfficerJul 26, 2025
Statement Of Utilization/ Deviation Of Funds Of Preferential Issue For The Quarter Ended 30Th June 2025Jul 26, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sJul 26, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsJul 26, 2025
Results- Financial Results For The Quarter Ended On 30Th June 2025Jul 26, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 26Th July 2025Jul 26, 2025
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2025Jul 21, 2025

Technical Indicators

RSI(14)
Neutral
44.86
ATR(14)
Volatile
7.34
STOCH(9,6)
Neutral
38.97
STOCH RSI(14)
Neutral
42.18
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
14.34
UO(9)
Bearish
47.94
ROC(12)
Downtrend And Accelerating
-14.83
WillR(14)
Neutral
-66.98